BioSpace News Archive

Apotex Inc., Canada’s leading pharmaceutical manufacturer of generic medicines, announced the Canadian launch of APO-Teriflunomide™ tablets, a generic version of Aubagio®, for the treatment of relapsing remitting multiple sclerosis.

LabConnect, Inc. is pleased to announce the appointment of Ms. Dawn Sherman to serve as its Chief Executive Officer and member of the Board of Directors.

Mirvie, a pioneer in predicting unexpected pregnancy complications, announced it has raised a total of $90 million to date following the close of its Series B funding.

Brain health supplements are made from natural substances or extracts from herbs or plants that essentially boost memory function, attention, focus, and alertness in healthy adults. They have also been proven to be highly effective in the management of sleep, depression, and anxiety.

Aquavit Pharmaceuticals, Inc. announced that it has appointed Senior Vice President Timothy Sherwood as Chief Operating Officer.

An increase in demand for laboratory automation is expected to fuel the adoption of laboratory informatics in the coming years.

EV Biologics Corp announced that it has signed a Manufacturing Services Agreement with Lonza for development of stem/progenitor cell-derived nanotherapeutics and scalable biomanufacturing process.

POXEL SA, a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis and rare metabolic disorders, provided a corporate update and announced its cash position and revenue for the first quarter ended March 31, 2022.

Nimble Therapeutics Inc. announced the company has achieved the first development milestone for each of several programs attached to a multi-target collaboration with an undisclosed large pharma partner.

Scientific Industries, Inc., a life sciences tool provider, and a developer of digitally simplified bioprocessing products, yesterday reported financial results for the three and nine month periods ended March 31, 2022.